Survivorship care

Recurrence Detection and Secondary Cancer Prevention: Survivorship care involves the vigilant monitoring for both recurrence of the primary malignancy and the potential emergence of secondary neoplasms, often as a consequence of oncologic therapies (e.g., radiation-induced malignancies). Structured, evidence-based follow-up schedules are implemented, incorporating regular imaging, laboratory testing, and clinical evaluations tailored to the specific treatment history of the patient.

Chronic Toxicity Management: Cancer therapies can induce a spectrum of chronic toxicities. Survivorship care encompasses the identification and management of treatment-related sequelae, such as chemotherapy-induced cardiotoxicity, cognitive impairments (often referred to as “chemobrain”), endocrine dysfunction (particularly hypothyroidism or ovarian failure), and persistent neuropathy. These issues necessitate a multidisciplinary approach, involving oncologists, cardiologists, neurologists, endocrinologists, and rehabilitation specialists.

Integrated Healthcare Delivery: Survivorship care demands an integrated, team-based approach. Oncologists, primary care providers, endocrinologists, cardiologists, psychologists, and rehabilitation specialists collaborate to develop an individualized, patient-centered care plan. This holistic model ensures that physical, psychological, and social domains of health are concurrently addressed, recognizing the complex and often multi-dimensional challenges survivors face.

Survivorship Care Plans: A formalized survivorship care plan (SCP) is often developed and provided to survivors, outlining the specifics of their treatment history, surveillance schedules, potential long-term risks, and recommended interventions for secondary prevention. This plan is essential for guiding both patients and healthcare providers in navigating the post-treatment phase, ensuring continuity of care.